Sarepta Therapeutics Inc (NASDAQ:SRPT)

118.09
Delayed Data
As of Apr 23
 +4.30 / +3.78%
Today’s Change
74.51
Today|||52-Week Range
176.50
+8.21%
Year-to-Date
3 Stocks Warren Buffett Would Love
Apr 23 / MotleyFool.com - Paid Partner Content
Wave Life Sciences Plunges After DMD Study Data Readout
Apr 17 / Zacks.com - Paid Partner Content
Columbus Circle Investors Buys Facebook Inc, PayPal Holdings Inc, Royal Caribbean Cru...
Apr 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close113.79
Today’s open113.98
Day’s range112.54 - 118.35
Volume1,422,139
Average volume (3 months)1,264,439
Market cap$8.6B
Data as of 4:00pm ET, 04/23/2019

Growth & Valuation

Earnings growth (last year)-535.22%
Earnings growth (this year)+17.96%
Earnings growth (next 5 years)+225.86%
Revenue growth (last year)+94.74%
P/E ratioNM
Price/Sales24.02
Price/Book8.03

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+1.47+0.89%
BHCValeant Pharmaceutic...+0.55+2.40%
ALNYAlnylam Pharmaceutic...+4.25+5.11%
JAZZJazz Pharmaceuticals...+3.81+3.02%
Data as of 4:00pm ET, 04/23/2019

Financials

Next reporting dateMay 9, 2019
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$301.0M
Annual profit (last year)-$361.9M
Net profit margin-120.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Chief Financial &
Business Officer, Executive VP
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts